e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cellular and molecular aspects of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension
S. Pizarro, M. Diez, V. I. Peinado, Y. Torralba, V. Delgado, J. Petriz, M. Sitges, P. Marín, M. T. Melgosa, J. Roca, J. A. Barberà (Barcelona, Spain)
Source:
Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Session:
Cellular and molecular aspects of pulmonary hypertension
Session type:
Electronic Poster Discussion
Number:
499
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pizarro, M. Diez, V. I. Peinado, Y. Torralba, V. Delgado, J. Petriz, M. Sitges, P. Marín, M. T. Melgosa, J. Roca, J. A. Barberà (Barcelona, Spain). Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension. Eur Respir J 2007; 30: Suppl. 51, 499
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Distinct patterns of circulating endothelial cells in pulmonary hypertension
Source: Eur Respir J 2010; 36: 1284-1293
Year: 2010
Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Effect of targeted therapy on circulating endothelial progenitor cells in precapillary pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Source: Eur Respir J 2006; 27: 529-541
Year: 2006
Endothelial progenitor cells in chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Year: 2007
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension
Source: Eur Respir J 2010; 36: 1302-1314
Year: 2010
Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Endothelial progenitor cells and pulmonary vascular remodeling in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 435s
Year: 2004
Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011
Decreased number of circulating endothelial progenitor cells in patients with emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Plasticity of vascular progenitor cells: implications in pulmonary vascular remodeling in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 803s
Year: 2006
Effects of endurance exercise training on circulating endothelial progenitor cells and endothelial microparticles in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Endothelial progenitor cells in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment
Year: 2008
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
Source: Eur Respir J 2011; 37: 1392-1399
Year: 2011
Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept